# Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

> **NCT05089279** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 71 (actual)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** D113
- **DRUG:** CKD-349

## Key facts

- **NCT ID:** NCT05089279
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-03
- **Primary completion:** 2022-01-18
- **Final completion:** 2022-04-06
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05089279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05089279, "Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05089279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*